Depression News

Patients with rheumatoid arthritis — either seropositive or seronegative — demonstrate a 1.66-fold higher risk for depression vs. healthy controls, according to data published in JAMA Network Open.

MindBio Therapeutics has announced positive topline results from its take-home phase 2a clinical trial of MB22001 in patients with depression, according to a company press release.

The number of adolescents and young adults with prescriptions for antidepressants accelerated during and after the COVID-19 pandemic, according to research published in Pediatrics.

The elevated propensity for peripheral artery disease in patients with major depression may be mediated by increased liability for lifetime smoking and BMI, according to research in the Journal of the American Heart Association.

Individuals with vision impairment have greater odds of experiencing symptoms of depression, anxiety and social isolation, according to new research published in JAMA Ophthalmology.

Individuals with mania who were admitted to an acute care psychiatric unit saw greater sleep improvement than patients with major depressive disorder, according to a study.

U.S. policy changes are needed to reduce perinatal mental health deserts, standardize social determinants of health data, improve psychiatric curriculums and establish paid parental leave, researchers reported in JAMA Psychiatry.

Patients hospitalized for depression appeared at greatest risk for suicide within the first week after discharge, according to a study conducted in Finland and published in JAMA Psychiatry.

A woman in her late 50s is currently receiving treatment for her second bout of breast cancer. She is thought to be in remission, but Neelam Desai, MD, worries about more than just the disease.

Patients with diabetes on one of several GLP-1 receptor agonists were less likely to be diagnosed with depression and anxiety compared with those not on those medications, researchers found.